BioMarin Pharmaceutical (Nasdaq: BMRN) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Recent Mentions on Fool.com
- Why BioMarin Pharmaceutical Inc. Roared 14% Higher in October
- The 5 Most Expensive Drugs in the World
- BioMarin Pharmaceutical Inc. Earnings: Striving to Be a Blockbuster Company
- BioMarin's Q1 Loss Shrinks 79% Due to Higher Rare Disease Drug Sales
- Today's Biotech Stocks to Watch: BioMarin Pharmaceutical Inc, InterMune, Inc. and Seattle Genetics I